Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119448664 | 11944866 | 4 | F | 201512 | 20160824 | 20160125 | 20160906 | PER | US-PFIZER INC-2016010378 | PFIZER | 68.00 | YR | F | Y | 0.00000 | 20160906 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119448664 | 11944866 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | 37.5 MG, DAILY | Y | 21938 | 37.5 | MG | CAPSULE, HARD | |||||||
| 119448664 | 11944866 | 2 | SS | SUTENT | SUNITINIB MALATE | 1 | 25 MG, ^4 WEEKS ON AND 2 WEEKS OFF^ | Y | 21938 | 25 | MG | CAPSULE, HARD | |||||||
| 119448664 | 11944866 | 3 | C | VALSARTAN. | VALSARTAN | 1 | UNK | 0 | |||||||||||
| 119448664 | 11944866 | 4 | C | CARVEDILOL. | CARVEDILOL | 1 | UNK | 0 | |||||||||||
| 119448664 | 11944866 | 5 | C | LASIX | FUROSEMIDE | 1 | UNK | 0 | |||||||||||
| 119448664 | 11944866 | 6 | C | MAGNESIUM | MAGNESIUM | 1 | UNK | 0 | |||||||||||
| 119448664 | 11944866 | 7 | C | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | 5 MG, 1X/DAY | 0 | 5 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119448664 | 11944866 | 1 | Pancreatic neuroendocrine tumour metastatic |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119448664 | 11944866 | Blood calcium abnormal | |
| 119448664 | 11944866 | Blood pressure systolic increased | |
| 119448664 | 11944866 | Confusional state | |
| 119448664 | 11944866 | Constipation | |
| 119448664 | 11944866 | Contusion | |
| 119448664 | 11944866 | Diarrhoea | |
| 119448664 | 11944866 | Disease progression | |
| 119448664 | 11944866 | Dysgeusia | |
| 119448664 | 11944866 | Epistaxis | |
| 119448664 | 11944866 | Feeling abnormal | |
| 119448664 | 11944866 | Pancreatic neuroendocrine tumour metastatic | |
| 119448664 | 11944866 | Pruritus | |
| 119448664 | 11944866 | Red blood cell count decreased | |
| 119448664 | 11944866 | Swelling face | |
| 119448664 | 11944866 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119448664 | 11944866 | 1 | 201503 | 0 |